FDA, FTC warn companies for selling illegal, unapproved opioid cessation products using deceptive claims
FDA and FTC issued joint warning letters to the marketers and distributors of 12 opioid cessation products, for illegally marketing unapproved products with claims about their ability to help in the treatment of opioid addiction and withdrawal
